Dawn Svoronos has bought stock on 4 days since May 2017

Dawn Svoronos is a Canadian pharmaceutical executive and corporate director who serves as Chair of the Board of Xenon Pharmaceuticals Inc., where she has been a board member since September 2016 and became Chair in June 2024 after previously acting as Lead Independent Director.( As a director and recent insider in Xenon Pharmaceuticals (XENE), she brings more than three decades of global biopharmaceutical commercial leadership, having held senior roles across Europe, Canada, Asia Pacific, and global marketing.(

Prior to her board career, Svoronos spent 23 years at Merck & Co., Inc., culminating as President, Europe & Canada, and previously served as President of Merck Canada, Vice President of Asia Pacific, and Global Marketing leader for Merck’s arthritis, analgesics, and osteoporosis franchises.( She has since built an extensive portfolio of board roles at publicly traded biopharmaceutical companies, including Adverum Biotechnologies, Theratechnologies, and others, as well as advisory positions in the biosciences industry.( Svoronos holds a B.A. in English and French Literature from Carleton University, providing a humanities foundation for her international leadership and governance work in the life sciences sector.(

Written by Perplexity from public sources.